Skip to main content

Volume 16 Supplement 1

1st Joint ANIRCEF-SISC Congress

The value of epidemiology in headache

Headache is the commonest neurological condition worldwide. According to the Global Burden of Disease 2010, tension-type headache is the second most common clinical condition (prevalence, 20.8%) preceded only by dental caries and followed by migraine (prevalence, 14.7%)[1]. Globally, migraine is the leading cause of disability-adjusted life years (DALY) and years living with disability (YLD). This information was obtained from epidemiological studies in developed and in developing countries where well-defined populations were investigated in search of people suffering from headache. Epidemiological studies estimate the frequency, spectrum and burden of a disease in a population. Headache, in this regard, has peculiar aspects that cannot be fully explored when studying referral patients (i.e., individuals seen in hospital, headache centers and other outpatient services) as the majority of patients do not have access to hospital facilities and several individuals do not even ask for medical consultation. However, in light of the frequency of headache in the population, the disease has a high impact on the society in terms of functional disability and indirect costs[2].

As several epidemiological studies are based on telephone interviews, the full spectrum of the disease can be easily captured on a population basis. Epidemiological studies are also instrumental when addressing the role of personal and environmental risk factors and their association with headache (migraine) types[3]. However, the representativeness of the study population is a pre-requisite for the external validity of the results. In addition, in the absence of valid and reliable biomarkers, the diagnosis of headache still relies mostly on clinical findings[4]. In this regard, epidemiology largely contributes to the identification of symptoms and signs most likely to differentiate the main diagnostic categories of the disease.

References

  1. 1.

    Stovner LJ, Hoff JM, Svajheim S, Gilhus NE: Neurological disorders in the Global Burden of Disease 2010 study. Acta Neurol Scand. 2014, 129 (Suppl 198): 1-6.

    Article  Google Scholar 

  2. 2.

    Lanteri-Minet M: Economic burden and costs of chronic migraine. Curr Pain Headache Rep. 2014, 18: 385-

    Article  PubMed  Google Scholar 

  3. 3.

    Merikangas KR: Contributions of epidemiology to our understanding of migraine. Headache. 2013, 53: 230-246. 10.1111/head.12038.

    Article  PubMed  Google Scholar 

  4. 4.

    Zhang Y, Kong Q, Chen J, Li L, Wang D, Zhou J: International Classification of Headache Disorders 3rd edition beta-based field testing of vestibular migraine in China: Demographic, clinical characteristics, audiometric findings and diagnosis statues. Cephalalgia. 2015, 0333102415587704-[Epub ahead of print]

    Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Ettore Beghi.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Beghi, E. The value of epidemiology in headache. J Headache Pain 16, A43 (2015). https://doi.org/10.1186/1129-2377-16-S1-A43

Download citation

Keywords

  • Migraine
  • Epidemiological Study
  • Dental Caries
  • Functional Disability
  • Global Burden